HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)
An Adaptive Randomized Evaluation of Nurse-Led HIV Treatment Retention Interventions for Women Living With HIV in Durban, South Africa
1 other identifier
interventional
1,391
1 country
1
Brief Summary
The Siyaphambili Study is a sequential multistage adaptive randomized trial (SMART) to compare the effectiveness and durability of two behavioral interventions on the HIV-1 virologic response among female sex workers (FSW) living with HIV in Durban, South Africa. The interventions are: 1) nurse-led decentralized treatment program (DTP) and 2) individualized case management (ICM). Viral suppression is defined as a viral load assessment \<50 RNA copies/mL. The design will also estimate the incremental cost-effectiveness of study interventions and combinations of interventions compared with maintaining the South African standard of HIV care and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2018
CompletedFirst Posted
Study publicly available on registry
April 17, 2018
CompletedStudy Start
First participant enrolled
June 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 24, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2022
CompletedResults Posted
Study results publicly available
September 21, 2023
CompletedJanuary 14, 2026
December 1, 2025
3.4 years
April 9, 2018
May 31, 2023
December 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Participants Retained and Virally Suppressed Among Those Receiving the DTP Versus ICM Arms
Retention and viral suppression at 18 months in those initially randomized to DTP vs. ICM. Participants are considered to be retained in care if they attended their 18-month final study visit and were engaged in care at 18-months. Viral suppression is defined as having less than 50 viral copies per milliliter.
18 months after enrollment
Secondary Outcomes (10)
Retention and Viral Suppression of Non-Responders
18 months after enrollment
Risk Factors of Loss to Follow-up
Up to 18 months after enrollment
Durability of Retention and Viral Suppression of Responders
Up to 18 months after enrollment
Adherence Assessment
18 months
Viral Suppression of Retained
Up to 18 months after enrollment
- +5 more secondary outcomes
Other Outcomes (3)
Decentralized Treatment Provision (DTP) Pick-Ups
Up to 18 months after enrollment
ICM Phone-Based Contacts
Up to 18 months after enrollment
ICM In-Person Meetings
Up to 18 months after enrollment
Study Arms (9)
DTP, Continue DTP if Responsive
ACTIVE COMPARATORDTP: * Standard of care (SoC), minus clinic referrals for antiretroviral therapy (ART) treatment initiation and management. * Nurse initiated and managed ART within the community on mobile van at sites served by the mobile van which already provides SoC services Continues with DTP intervention if virally suppressed at 6 months.
DTP, Standard of Care (SoC) if Responsive
ACTIVE COMPARATORDTP: * Standard of care, minus clinic referrals for ART treatment initiation and management. * Nurse initiated and managed ART within the community on mobile van at sites served by the mobile van which already provides SoC services SoC: * HIV counseling and testing (HTC) * Sexually transmitted infection (STI) screening and treatment * Tuberculosis (TB) screening and referral * Health education through peer educators and peer supported follow-up related to linkages to care * Referrals to Department of Health (DoH) primary healthcare clinics or TB HIV Care (THC) drop-in center for ART treatment initiation and management Returns to SoC if virally suppressed at 6 months.
DTP, Continue DTP if Non-Responsive
ACTIVE COMPARATORDTP: * Standard of care, minus clinic referrals for ART treatment initiation and management. * Nurse initiated and managed ART within the community on mobile van at sites served by the mobile van which already provides SoC services Continues with DTP intervention if not virally suppressed at 6 months.
DTP, DTP+ICM if Non-Responsive
ACTIVE COMPARATORDTP: * Standard of care, minus clinic referrals for ART treatment initiation and management. * Nurse initiated and managed ART within the community on mobile van at sites served by the mobile van which already provides SoC services ICM: * Standard of Care * Assignment of peer case manager * Face-to-face meeting to tailor ICM approach to FSW preference * Self-efficacy building in face-to-face sessions and bi-weekly text messages * Relational support through monthly calls, face-to-face meetings every three months, and additional support through female sex worker (FSW) initiated interaction Receives both interventions at 6 months if non-virally suppressed.
ICM, Continue ICM if Responsive
ACTIVE COMPARATORICM: * Standard of Care * Assignment of peer case manager * Face-to-face meeting to tailor ICM approach to FSW preference * Self-efficacy building in face-to-face sessions and bi-weekly text messages * Relational support through monthly calls, face-to-face meetings every three months, and additional support through FSW initiated interaction Continues with ICM intervention at 6 months if virally suppressed.
ICM, SoC if Responsive
ACTIVE COMPARATORICM: * Standard of Care * Assignment of peer case manager * Face-to-face meeting to tailor ICM approach to FSW preference * Self-efficacy building in face-to-face sessions and bi-weekly text messages * Relational support through monthly calls, face-to-face meetings every three months, and additional support through FSW initiated interaction SoC: * HIV counseling and testing (HTC) * STI screening and treatment * TB screening and referral * Health education through peer educators and peer supported follow-up related to linkages to care * Referrals to DOH primary healthcare clinics or THC drop-in center for ART treatment initiation and management Returns to SoC if virally suppressed at 6 months.
ICM, Continue ICM if Non-Responsive
ACTIVE COMPARATORICM: * Standard of Care * Assignment of peer case manager * Face-to-face meeting to tailor ICM approach to FSW preference * Self-efficacy building in face-to-face sessions and bi-weekly text messages * Relational support through monthly calls, face-to-face meetings every three months, and additional support through FSW initiated interaction Continues with ICM intervention at 6 months if non-virally suppressed.
ICM, ICM+DTP if Non-Responsive
ACTIVE COMPARATORICM: * Standard of Care * Assignment of peer case manager * Face-to-face meeting to tailor ICM approach to FSW preference * Self-efficacy building in face-to-face sessions and bi-weekly text messages * Relational support through monthly calls, face-to-face meetings every three months, and additional support through FSW initiated interaction DTP: * Standard of care, minus clinic referrals for ART treatment initiation and management. * Nurse initiated and managed ART within the community on mobile van at sites served by the mobile van which already provides SoC services Receives both interventions at 6 months if non-virally suppressed.
Standard of Care (SoC)
NO INTERVENTIONStandard of Care (SoC): * HIV counseling and testing (HTC) * Sexually transmitted infection (STI) screening and treatment * Tuberculosis (TB) screening and referral * Health education through peer educators and peer supported follow-up related to linkages to care * Referrals to Department of Health (DoH) primary healthcare clinics or TB HIV Care (THC) drop-in center for ART treatment initiation and management
Interventions
Provision of antiretroviral therapy (ART) in the community through a mobile-van DTP managed by a nurse capable of initiating and managing ART.
Peer-led ICM through quarterly face-to-face meetings, monthly phone calls and biweekly text messages.
Eligibility Criteria
You may qualify if:
- Sells sex for goods or money as their main source of income
- Assigned female sex at birth
- ≥ 18 years of age
- Living with HIV; diagnosed ≥ 6 months prior
- Currently living in Durban
- If on ART, initiated ≥2 months prior
You may not qualify if:
- Engagement in an ongoing HIV treatment research study
- Planning on leaving Durban for more than 3 months in the following 12 months
- Pregnant at time of enrollment
- On a second line or third ART regimen
- Participating in an adherence club
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Torontocollaborator
- University of California, San Franciscocollaborator
- National Institute for Communicable Diseases, South Africacollaborator
- Johns Hopkins Bloomberg School of Public Healthlead
- University of the Western Capecollaborator
- TB HIV Carecollaborator
Study Sites (1)
TB HIV Care
Durban, South Africa
Related Publications (5)
Comins CA, Genberg B, Mcingana M, Bandeen-Roche K, Phetlhu DR, Steingo J, Mishra S, Wang L, Baral S, Hausler H, Schwartz S. Longitudinal Trajectories of Engagement With HIV Treatment Support Strategies Among Female Sex Workers Living With HIV in South Africa. J Acquir Immune Defic Syndr. 2025 Dec 1;100(4):323-330. doi: 10.1097/QAI.0000000000003738.
PMID: 40810449DERIVEDComins CA, Baral S, Mcingana M, Shipp L, Phetlhu DR, Young K, Guddera V, Hausler H, Schwartz S. ART coverage and viral suppression among female sex workers living with HIV in eThekwini, South Africa: Baseline findings from the Siyaphambili study. PLOS Glob Public Health. 2024 May 22;4(5):e0002783. doi: 10.1371/journal.pgph.0002783. eCollection 2024.
PMID: 38776334DERIVEDBhardwaj A, Comins CA, Guddera V, Mcingana M, Young K, Phetlhu R, Mulumba N, Mishra S, Hausler H, Baral S, Schwartz S. Prevalence of depression, syndemic factors and their impact on viral suppression among female sex workers living with HIV in eThekwini, South Africa. BMC Womens Health. 2023 May 5;23(1):232. doi: 10.1186/s12905-023-02392-2.
PMID: 37147708DERIVEDChen C, Baral S, Comins CA, Mcingana M, Wang L, Phetlhu DR, Mulumba N, Guddera V, Young K, Mishra S, Hausler H, Schwartz SR. HIV- and sex work-related stigmas and quality of life of female sex workers living with HIV in South Africa: a cross-sectional study. BMC Infect Dis. 2022 Dec 6;22(1):910. doi: 10.1186/s12879-022-07892-4.
PMID: 36474210DERIVEDWang L, Dowdy DW, Comins CA, Young K, Mcingana M, Mulumba N, Mhlophe H, Chen C, Hausler H, Schwartz SR, Baral S, Mishra S; Siyaphambili Study team. Health-related quality of life of female sex workers living with HIV in South Africa: a cross-sectional study. J Int AIDS Soc. 2022 Feb;25(2):e25884. doi: 10.1002/jia2.25884.
PMID: 35212470DERIVED
Limitations and Caveats
A limitation to this study has been determining engagement in care and viral load status for those who were lost to follow up (LTFU) in the trial in order to inform the primary outcome. Given the high rates of LTFU, participants may have been seeking care elsewhere and achieved viral suppression during the follow up period without our knowledge. This has implications for our primary outcome which uses an intention to treat (ITT) analysis of engagement in care and viral suppression.
Results Point of Contact
- Title
- Dr. Stefan Baral
- Organization
- Johns Hopkins Bloomberg School of Public Health
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Baral, MD, MPH
Johns Hopkins Bloomberg School of Public Health
- PRINCIPAL INVESTIGATOR
Harry Hausler, MD, MPH
TB HIV Care
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2018
First Posted
April 17, 2018
Study Start
June 22, 2018
Primary Completion
November 24, 2021
Study Completion
January 5, 2022
Last Updated
January 14, 2026
Results First Posted
September 21, 2023
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share